SPG.F Springer Nature AG & Co KGaA
- Market cap
- EUR 4.54B
- P/E
- 13.8x
- P/B
- 2.23x
- ROE
- 17.6%
- Dividend yield
- 0.57%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is SPG.F undervalued?
Graham numberSPG.F trades 16.8% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Springer Nature AG & Co KGaA fundamental analysis
No fundamental analysis for Springer Nature AG & Co KGaA yet.
Springer Nature AG & Co KGaA stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Springer Nature AG & Co KGaA
Springer Nature AG & Co. KGaA, together with its subsidiaries, engages in the publishing business in Germany, the United Kingdom, the United States, and internationally. The company operates through three segments: Research, Education, and Health. It offers journals across various academic disciplines under the Nature Portfolio and Springer brand names; books in print and digital formats across various scientific disciplines, including monographs, textbooks, conference proce…
Full company profileSpringer Nature AG & Co KGaA financial statements
Springer Nature AG & Co KGaA annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Income Statement | |||
| Revenue | 1.85B | 1.85B | 1.93B |
| Gross Profit | 1.59B | 1.61B | 1.68B |
| Operating Income | 406M | 404M | 463M |
| EBITDA | 665M | 616M | 773M |
| Net Income | 15.5M | 68.3M | 356M |
| EPS | - | 0.34 | 1.79 |
| Balance Sheet | |||
| Total Assets | 5.41B | 5.39B | 4.98B |
| Total Liabilities | 5.37B | 3.57B | 2.96B |
| Shareholders' Equity | 35.5M | 1.81B | 2.03B |
| Cash & Short-term Investments | 274M | 300M | 270M |
| Cash Flow | |||
| Operating Cash Flow | 492M | 531M | 549M |
| Capital Expenditure | 45.1M | 41.5M | 29.0M |
| Free Cash Flow | 447M | 490M | 520M |
| Ratios | |||
| ROE | 43.7% | 3.8% | 17.6% |
| ROA | 0.3% | 1.3% | 7.1% |
| Net Profit Margin | 0.8% | 3.7% | 18.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Springer Nature AG & Co KGaA dividends
- Dividend yield
- 0.57%
- Forward dividend
- 0.13 EUR
- Payout ratio
- 7.3%
- Ex-dividend date
- Jun 6, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 25.9M | 0.13 | 7.3% |
| 2024 | - | - | - |
| 2023 | EUR 200K | - | 1.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Springer Nature AG & Co KGaA
- Insiders 82.74%
- Institutions 8.11%
- Public & others 9.15%
- Shares outstanding 199M
- Free float 26.7M
Springer Nature AG & Co KGaA company profile
- Company name
- Springer Nature AG & Co KGaA
- Ticker
- SPG.F
- ISIN
- DE000SPG1003
- Exchange
- Frankfurt Exchange
- Sector
- Communication Services
- Industry
- Publishing
- Employees
- 9,400
- Fiscal year end
- December
- Address
- Heidelberger Platz 3, Berlin, Germany, 14197
- Phone
- 49 30 827 870
- Website
- springernature.com
About Springer Nature AG & Co KGaA
Springer Nature AG & Co. KGaA, together with its subsidiaries, engages in the publishing business in Germany, the United Kingdom, the United States, and internationally. The company operates through three segments: Research, Education, and Health. It offers journals across various academic disciplines under the Nature Portfolio and Springer brand names; books in print and digital formats across various scientific disciplines, including monographs, textbooks, conference proceedings, handbook series, reference works, and briefs under the Springer and Palgrave Macmillan brand names; and support services to researchers, institutions, and industry professionals with AI-powered tools and services, such as AdisInsight, Springer Nature Experiments, protocols.io, and SpringerMaterials, as well as professional development and career services under the Nature Masterclasses, Nature Careers, and Nature Conferences brand names. The company also provides English language teaching content and national curricula learning resources under the Macmillan Education brand name. In addition, it offers specialist information and services to healthcare professionals under the Springer Medizin brand name; publications, learning solutions, and professional services to healthcare practitioners and students under the BSL brand name; content and services related to drug treatments, medical devices, and diagnostics under the Springer Health+ brand name; and Cureus Journal of Medical Science, a peer-reviewed OA medical journal. The company was founded in 1842 and is based in Berlin, Germany. Springer Nature AG & Co. KGaA operates as a subsidiary of GvH Vermögensverwaltungsgesellschaft Xxxiii mbH.
Springer Nature AG & Co KGaA management
10- Mr. Franciscus Vrancken PeetersCEO & Chairman of the Management Board · born 1966
- Ms. Rachel JacobsGroup General Counsel & Member of the Management Board · born 1975
- Dr. Harshavardhan JegadeesanChief Publishing Officer & Member of the Management Board · born 1981
- Ms. Carolyn HonourChief Commercial Officer & Member of the Management Board · born 1960
- Mr. Marc SpenleCOO & Member of the Management Board · born 1972
- Mr. Patric SomloCFO & Member of Management Board
- Mr. Matthias WisselChief Information Officer
- Dr. Ritu DhandChief Scientific Officer
- Mr. Tom WaldronHead of Investor Relations
- Ms. Joyce LoriganGroup Head of Corporate Affairs & Chief Marketing Officer